Cydan
ProfileJobs

Cydan

Suggest Edit
    • Healthacceleratorbiotechpharma
    Cydan is an orphan drug accelerator that identifies and de-risks compounds with therapeutic and commercial potential. Their rigorous process generates data to support a development path and new company formation. Cydan’s experienced and globally networked team brings strong relationships with academia and patient advocacy, deep expertise in drug development, and a track record of successful product commercialization.
    Total Funding
    $60 M
    Type
    Private
    HQ
    Lincoln, US
    Founded
    2012
    Size (employees)
    10 (est)+12%
    Website
    cydanco.com
    Cydan was founded in 2012 and is headquartered in Lincoln, US
    Report incorrect company information

    Cydan Office Locations

    Cydan has an office in Lincoln
    Lincoln, US (HQ)
    16 Conant Road
    Show all (1)
    Report incorrect company information

    Cydan Financials and Metrics

    Summary Metrics

    Founding Date

    		2012

    Total Funding

    		$60 m

    Latest funding size

    		$34 m

    Time since last funding

    		8 months ago

    Investors

    		Pfizer Venture Investments, Alexandria Venture Investments, New Enterprise Associates, Lundbeckfonden Ventures, Bay City Capital, Longitude Capital
    Cydan's latest funding round in October 2017 was reported to be $34 m. In total, Cydan has raised $60 m
    Show all financial metrics
    Report incorrect company information

    Competitors

    NovaBay Pharmaceuticals
    Health - Public
    Chiasma
    Health - Public
    LGC Biosearch Technologies
    Health - Subsidiary
    Loxo Oncology
    Health - Public
    Compare competitors

    Cydan Online and Social Media Presence

    Embed Graph
    Report incorrect company information
    Download PDF